The U.S. Food and Drug Administration (FDA) approved a new, twice-yearly shot — the first and only of its kind — to prevent ...

The Food and Drug Administration (FDA) has approved the HIV preventing drug, lenacapavir, which only has to be administered twice a year. The injectable drug, sold as Yeztugo, can be taken by those at ...

The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection ...

The US Food and Drug Administration (FDA) has approved the long-acting injection Lenacapavir for the prevention of HIV ...

The shot nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take.

Researchers at the University of Liverpool have indicated that this HIV prevention drug could be manufactured and rolled out at around $40 per person per year.